Dr. Xu is a Principal Biostatistician at the Princess Margaret Cancer Center, a Scientist at the Ontario Cancer Institute, and an Associate Professor of Biostatistics at Dalla Lana School of Public Health, University of Toronto. As Principal-Investigator or co-Investigator, he has been involved in study design, data administration, statistical modeling development and data analysis on different clinical research and human genetic studies. He has published over 250 peer-reviewed papers in the field of statistics, bioinformatics, medical science and human genetics.
Dr. Xu’s research interests focus on clinical trial design and methodology, biostatistics and bioinformatics methodology, statistical genetics, and cancer clinical and translational research.
Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
Oral Oncol. 2019 Jun;93:96-100
Copy number variation-based gene set analysis reveals cytokine signalling pathways associated with psychiatric comorbidity in patients with inflammatory bowel disease.
Genomics. 2019 May 07;:
Nat Genet. 2019 May;51(5):793-803
Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
Radiother Oncol. 2019 May;134:10-16
Implementation of a Novel Electronic Patient-Directed Smoking Cessation Platform for Cancer Patients: Interrupted Time Series Analysis.
J Med Internet Res. 2019 Apr 09;21(4):e11735
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2019 Apr 04;:
The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis.
Oncologist. 2019 Apr 05;:
The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids.
Cell Stem Cell. 2019 Apr 04;24(4):621-636.e16
Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM.
Oral Oncol. 2019 Apr;91:113-120
Cancer Med. 2019 Mar 21;:
Affiliate Scientist, Princess Margaret Cancer Centre
Principal Biostatistician, Princess Margaret Cancer Center, UHN
Associate Professor, Dalla Lana School of Public Health, University of Toronto